These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 38736312)
1. Quercetin induces ferroptosis by inactivating mTOR/S6KP70 pathway in oral squamous cell carcinoma. Zhu YW; Liu CL; Li XM; Shang Y Toxicol Mech Methods; 2024 Jul; 34(6):669-675. PubMed ID: 38736312 [TBL] [Abstract][Full Text] [Related]
2. TCF12 induces ferroptosis by suppressing OTUB1-mediated SLC7A11 deubiquitination to promote cisplatin sensitivity in oral squamous cell carcinoma. Liu Y; Bai Q; Pang N; Xue J Cell Biol Int; 2024 Nov; 48(11):1649-1663. PubMed ID: 38946134 [TBL] [Abstract][Full Text] [Related]
3. PPARγ Antagonists Exhibit Antitumor Effects by Regulating Ferroptosis and Disulfidptosis. Zhang S; Wang Y; Gu J; Yang Y; Liang J; Wang Y; Ji N; Liu M; Zhang Y; Sun S; Chen Q; Li J Biomolecules; 2024 May; 14(5):. PubMed ID: 38786003 [TBL] [Abstract][Full Text] [Related]
4. Effect and mechanism of resveratrol on ferroptosis mediated by p53/SLC7A11 in oral squamous cell carcinoma. Mao C; Gong L; Kang W BMC Oral Health; 2024 Jul; 24(1):773. PubMed ID: 38987730 [TBL] [Abstract][Full Text] [Related]
5. TIGAR Protects Against Adenine-Induced Ferroptosis in Human Proximal Tubular Epithelial Cells by Activating the mTOR/S6KP70 Axis. Tan QL; Zhang MX; Yao DH; Yan Y; Yang XF; Qin ZH; Gong Y; Meng Q Nutr Cancer; 2023; 75(6):1464-1472. PubMed ID: 37140263 [TBL] [Abstract][Full Text] [Related]
6. Astaxanthin Synergizes with Ionizing Radiation (IR) in Oral Squamous Cell Carcinoma (OSCC). Du Y; Shuai Y; Liu Z; Li H; Yin Y Mol Biotechnol; 2024 May; 66(5):1220-1228. PubMed ID: 38103098 [TBL] [Abstract][Full Text] [Related]
7. Hsa-miR-26a-5p improves OSCC sensitivity to ferroptosis by inhibiting SLC7A11. Liang B; Wu Y Arch Oral Biol; 2023 Dec; 156():105807. PubMed ID: 37776596 [TBL] [Abstract][Full Text] [Related]
8. Zerumbone targets the CXCR4-RhoA and PI3K-mTOR signaling axis to reduce motility and proliferation of oral cancer cells. Zainal NS; Gan CP; Lau BF; Yee PS; Tiong KH; Abdul Rahman ZA; Patel V; Cheong SC Phytomedicine; 2018 Jan; 39():33-41. PubMed ID: 29433681 [TBL] [Abstract][Full Text] [Related]
9. LncRNA FOXD2-AS1 promotes the growth, invasion and migration of OSCC cells by regulating the MiR-185-5p/PLOD1/Akt/mTOR pathway. Liu J; Zhang Y; Wu J; Liu X; Li L; Zhang J Cancer Genet; 2024 Jun; 284-285():48-57. PubMed ID: 38729078 [TBL] [Abstract][Full Text] [Related]
10. MiR-34c-3p upregulates erastin-induced ferroptosis to inhibit proliferation in oral squamous cell carcinomas by targeting SLC7A11. Sun K; Ren W; Li S; Zheng J; Huang Y; Zhi K; Gao L Pathol Res Pract; 2022 Mar; 231():153778. PubMed ID: 35093695 [TBL] [Abstract][Full Text] [Related]
11. Urolithin A, induces apoptosis and autophagy crosstalk in Oral Squamous Cell Carcinoma via mTOR /AKT/ERK1/2 pathway. Remadevi V; Jaikumar VS; Vini R; Krishnendhu B; Azeez JM; Sundaram S; Sreeja S Phytomedicine; 2024 Jul; 130():155721. PubMed ID: 38788395 [TBL] [Abstract][Full Text] [Related]
12. Increased expression of lncRNA CASC9 promotes tumor progression by suppressing autophagy-mediated cell apoptosis via the AKT/mTOR pathway in oral squamous cell carcinoma. Yang Y; Chen D; Liu H; Yang K Cell Death Dis; 2019 Jan; 10(2):41. PubMed ID: 30674868 [TBL] [Abstract][Full Text] [Related]
13. Quercetin suppresses the tumorigenesis of oral squamous cell carcinoma by regulating microRNA-22/WNT1/β-catenin axis. Zhang C; Hao Y; Sun Y; Liu P J Pharmacol Sci; 2019 Jun; 140(2):128-136. PubMed ID: 31257059 [TBL] [Abstract][Full Text] [Related]
14. CircPVT1 facilitates the progression of oral squamous cell carcinoma by regulating miR-143-3p/SLC7A11 axis through MAPK signaling pathway. Wang S; Li W; Yang L; Yuan J; Wang L; Li N; Zhao H Funct Integr Genomics; 2022 Oct; 22(5):891-903. PubMed ID: 35624316 [TBL] [Abstract][Full Text] [Related]
15. Assessment of multiple pathways involved in the inhibitory effect of HCG22 on oral squamous cell carcinoma progression. Wang M; Feng Z; Li X; Sun S; Lu L Mol Cell Biochem; 2021 Jun; 476(6):2561-2571. PubMed ID: 33649984 [TBL] [Abstract][Full Text] [Related]
16. Amentoflavone suppresses cell proliferation and induces cell death through triggering autophagy-dependent ferroptosis in human glioma. Chen Y; Li N; Wang H; Wang N; Peng H; Wang J; Li Y; Liu M; Li H; Zhang Y; Wang Z Life Sci; 2020 Apr; 247():117425. PubMed ID: 32057904 [TBL] [Abstract][Full Text] [Related]
17. Metformin inhibits mTOR and c-Myc by decreasing YAP protein expression in OSCC cells. Wang Y; Zhang Y; Feng X; Tian H; Fu X; Gu W; Wen Y Oncol Rep; 2021 Mar; 45(3):1249-1260. PubMed ID: 33650651 [TBL] [Abstract][Full Text] [Related]
18. An Acid-Responsive Iron-Based Nanocomposite for OSCC Treatment. Zhao X; Leng D; Wang H; Jin H; Wu Y; Qin Z; Wu D; Wei X J Dent Res; 2024 Jun; 103(6):612-621. PubMed ID: 38684484 [TBL] [Abstract][Full Text] [Related]
19. Overexpression of T-cadherin inhibits the proliferation of oral squamous cell carcinoma through the PI3K/AKT/mTOR intracellular signalling pathway. Wang Q; Zhang X; Song X; Zhang L Arch Oral Biol; 2018 Dec; 96():74-79. PubMed ID: 30195142 [TBL] [Abstract][Full Text] [Related]
20. The circEPSTI1/mir-942-5p/LTBP2 axis regulates the progression of OSCC in the background of OSF via EMT and the PI3K/Akt/mTOR pathway. Wang J; Jiang C; Li N; Wang F; Xu Y; Shen Z; Yang L; Li Z; He C Cell Death Dis; 2020 Aug; 11(8):682. PubMed ID: 32826876 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]